Company news
Brainsway Ltd (TASE:BWAY) news
Every Brainsway Ltd press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation
August 27, 2026
BrainsWay Announces Minority-Stake Investment in Hopemark Health
May 18, 2026
BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026
April 29, 2026
BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 13, 2026
Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy...
March 30, 2026
BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD
March 26, 2026
BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health
March 19, 2026
BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
March 11, 2026
Landmark Data Validate BrainsWay’s SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment
March 4, 2026
BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026
February 25, 2026
BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day
February 23, 2026
BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.
February 19, 2026
BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access...
February 18, 2026
BrainsWay Announces Change in ADS-to-Ordinary Share Ratio
February 17, 2026
BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™
January 21, 2026
BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)
January 12, 2026
BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™
January 7, 2026
BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™
December 22, 2025
BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025
November 25, 2025
BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder
November 17, 2025
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21
November 13, 2025
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights
November 11, 2025
BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of A...
November 4, 2025
BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025
October 28, 2025
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
October 27, 2025
BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)
September 16, 2025
BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolie...
August 21, 2025
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
August 20, 2025
BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights
August 13, 2025
BrainsWay Champions TMS Education with Sponsorship of Two Free CME Courses for Mental Health Professionals
July 30, 2025
BrainsWay to Report Second Quarter 2025 Financial Results on August 13, 2025
July 30, 2025
BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)
June 11, 2025
BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego
June 10, 2025
BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC
June 4, 2025
BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights
May 13, 2025
BrainsWay to Showcase Deep TMS at the 2025 American Psychiatric Association Annual Meeting in Los Angeles
May 1, 2025
BrainsWay to Report First Quarter 2025 Financial Results on May 13, 2025
April 29, 2025
BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
March 11, 2025
BrainsWay to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
March 4, 2025
BrainsWay to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
February 24, 2025